Search – Page 206 – Indianapolis Business Journal

Home » Search

Articles

Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment

January 29, 2025 | Daniel Lee

The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.’s Omvoh, a new therapy to treat Chron’s disease and ulcerative colitis, is the company’s latest step into the treatment of gastrointestinal diseases.

Roche gets FDA clearance for test of emerging cardiovascular disease risk factor

February 5, 2025 | Daniel Lee

Lipoprotein(a) has long been recognized as a critical marker for people at risk of cardiovascular disease. However, the health care industry has lacked the tools to tackle the problem.

UPDATE: Lilly reports robust Q4, full-year earnings

February 6, 2025 | Daniel Lee

Lilly’s fourth-quarter earnings, released before the market opened Thursday, surpassed analysts’ expectations by millions.

Could obesity drugs help with alcohol cravings? New study suggests potential.

February 12, 2025 | Associated Press

The results add to evidence from animal studies and reports that people are finding the drugs helpful to manage cravings, not just for food, but also for tobacco and alcohol.

Corrections & clarifications

February 12, 2025 | IBJ Staff

IBJ corrects errors in stories and columns. When those are errors of fact or clarifications of context or tone, we will put those corrections here, with links to the corrected stories.

Lebanon planning board to review designs for Lilly’s $4.5B foundry at LEAP District

February 14, 2025 | Daniel Bradley

IMAGE GALLERY: The 200-acre Lilly Medicine Foundry is expected to add 400 full-time jobs for highly skilled workers, including engineers, scientists, operations personnel and lab technicians.

Tariffs could reach deep into manufacturing-heavy Indiana

February 14, 2025 | Daniel Lee

While consumers across the country could pay higher prices on all sorts of goods, Indiana’s economy is especially vulnerable to the uncertainty from tariffs and retaliatory tariffs between nations, economists say.

Trump casts psychiatric and weight-loss drugs as threats to children

February 17, 2025 | The Washington Post

President Donald Trump has instructed his administration to scrutinize the “threat” to children posed by antidepressants, stimulants and other common psychiatric drugs.

Lebanon planning board OKs design for Lilly Medicine Foundry at LEAP District

February 18, 2025 | Daniel Bradley

The foundry will give the pharmaceutical maker the ability to research new ways of producing medicines.

Weight-loss drugs aren’t just slimming waists. They’re shifting the economy.

February 24, 2025 | The Washington Post

Roughly 16 million people—that’s 6 percent of American adults—are taking GLP-1 weight-loss drugs, and that number is growing rapidly. Their collective purchasing power has the potential to profoundly reshape the economy.

Patients struggle with lack of consistent coverage for popular weight-loss drugs

February 24, 2025 | Associated Press

Supplies of high-demand obesity treatments are improving, but that doesn’t mean they’re easier to get.

LEAP spending nears $1B with projected budget shielded, investigation finds

February 24, 2025 | Leslie Bonilla Muñiz, Indiana Capital Chronicle

The LEAP Research and Innovation District, led by the Indiana Economic Development Corp., is among the costliest economic development projects Indiana has attempted. But the agency’s structure obscures its spending and who benefits.

Eli Lilly to spend $27B on four new manufacturing sites

February 26, 2025 | Daniel Lee

The new manufacturing sites are expected to create create 3,000 pharmaceutical jobs and nearly 10,000 construction positions during the buildout.

Republic Airways, Accutech Systems among 2025 Mira Award winners

February 27, 2025 | Susan Orr

Indianapolis-based TechPoint, which supports the state’s tech sector, honored Republic Airways, Accutech and 18 other winners at its annual Mira Awards gala Thursday night.

Commerce secretary wants to turn the IEDC inside out

February 28, 2025 | Cate Charron

In some ways, social media platforms are unlike traditional media platforms, such as radio and television. In other ways, they are very similar.

Lilly cuts undisclosed number of jobs, ‘nothing large scale’

March 5, 2025 | Daniel Lee

The reductions come at a time of significant growth overall for Lilly. and soon after the announcement of plans to build new manufacturing facilities at four yet-to-be-named U.S. locations.

Novo Nordisk cuts Wegovy prices, following similar move for Zepbound by Eli Lilly

March 5, 2025 | Associated Press

Novo Nordisk’s new offering follows a direct-to-consumer model that Eli Lilly launched last year.

Construction managers say uncertainty, demand keep most prices high

March 7, 2025 | Mickey Shuey

The labor pinch has affected several developments across Indianapolis, with some builders shuffling projects to accommodate subcontractor availability, a few halting the start of work altogether and others forging ahead after securing additional capital to pay higher prices.

Zepbound raises profile of Lilly’s direct-to-consumer sales initiative

March 7, 2025 | Daniel Lee

Indianapolis-based Eli Lilly and Co. launched LillyDirect a little more than a year ago and has been ramping up efforts to connect directly with consumers on the platform since.

Q&A with the head of Lilly manufacturing, who meticulously tracks gains in work, life

March 14, 2025 | Daniel Lee

“People come together, operators, with their supervisors at 6 a.m. every morning, and they talk about what issues they have and how they propose to solve it. Those get escalated through all levels of management.”

« Previous 1 … 204 205 206 207 208 … 221 Next »

Search Results

4,410 results for '\"eli lilly\"'